Broad experience in developing growth strategies for life science clients including both internal organic development and external transactions. Focus on helping life science clients in the emerging cellular and genetic therapies field including stem cell therapies and bioinformatics. Have led multiple change efforts across the value chain for both major biopharmas, emerging biotechs, medical device manufacturers, and private equity investors.Specialties: In-licensing, out-licensing, alliances, strategic planning, mergers & acquisitions, joint ventures, equity investments, international expansion, market analysis, clinical development, supply chain, manufacturing, market access, pricing and reimbursement